Senior leadership team further bolstered by appointment of Rick Evans to the newly created role of Social Strategy Director
London, UK; 27 May, 2021: Global healthcare communications consultancy 90TEN, part of Envision Pharma Group, today announced the promotions of Deputy Managing Director Claire Long and Client Services Director Sabrina Gomersall to the role of joint Managing Director. Together, Claire and Sabrina will lead the agency’s thriving Communications division into its next phase of growth.
“Claire and Sabrina have been instrumental in 90TEN’s evolution from an independent communications agency to an integral and valuable part of the Envision Pharma Group family, and I am thrilled that they will now be bringing their energy, creativity, and passion for life-changing communications to these roles,” said David Thompson, Chief Executive Officer, Envision Pharma Group. “90TEN is already recognised as one of the leading healthcare communications consultancies in Europe and we are now working towards taking its unique brand of behavioural science-led creative communications to new geographies around the world.”
90TEN also announced the appointment of Rick Evans to the newly created role of Social Strategy Director. Joining 90TEN from Ogilvy Health, Rick brings more than 14 years of experience in healthcare communications and social media strategy and a track record for designing and delivering creative campaigns. In this role, Rick will lead the expansion of 90TEN’s social media offering to bring new opportunities to the agency’s roster of healthcare, pharmaceutical and biotech clients with a focus on incorporating behavioural science-led methodologies into social media strategies that deliver meaningful outcomes.
Based in London, 90TEN employs around 70 members of staff and works with half of the top 20 pharma companies in the world serving clients across Europe and North America. In 2020 it became part of Envision Pharma Group – a global provider of evidence-based communication services and industry-leading technology solutions.
— Ends —
90TEN, part of the Envision Pharma Group, is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and communications. 90TEN provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximise brand and health outcomes. 90TEN is one of the leading healthcare communications consultancies in Europe and in 2020 it was named Communications Consultancy of the Year at both the Communiqué Awards and Sabre EMEA Awards. To find out more, visit www.90ten.co.uk.
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.
Envision has 20 offices: seven in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), Wilmslow, and Alderley Edge; one in Serbia – Subotica; one in Hungary – Szeged; one in Coimbra, Portugal, eight in the United States – Fairfield and Glastonbury, CT, Philadelphia and Wyomissing, PA, Warren, NJ, Boston and Melrose, MA, Powell, OH; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs over 1000 team members, including over 250 highly qualified and experienced in-house medical writers, over 200 technology solutions team members who provide software development and customer support. To find out more, visit www.envisionpharmagroup.com.
For further information, please contact:
+44 (0)7921 879 689